PG

Procter & Gamble

$144.68

+1.20%
Aug 21, 2026
Bobby Quantitative Model
Procter & Gamble (PG) is a global consumer goods giant, manufacturing and marketing a diversified portfolio of household and personal care products, including iconic brands like Tide, Pampers, and Gillette, across more than 180 countries. As one of the world's largest consumer product manufacturers with annual sales near $85 billion, it holds a dominant market position in categories such as laundry, diapers, and grooming, underpinned by strong brand equity and extensive distribution networks. The current investor narrative centers on PG's ability to navigate a challenging operating environment marked by input cost inflation and sluggish volume growth, as evidenced by recent fiscal 2027 guidance that fell short of expectations due to $1.36 billion in cost headwinds. Additionally, the stock's underperformance relative to the broader market has sparked debate about whether its defensive characteristics and dividend reliability justify a premium valuation in a period of economic uncertainty.

People also watch

Colgate-Palmolive Company

Colgate-Palmolive Company

CL

Analysis
Kenvue

Kenvue

KVUE

Analysis
Kimberly-Clark

Kimberly-Clark

KMB

Analysis
Estée Lauder Companies

Estée Lauder Companies

EL

Analysis
Church & Dwight

Church & Dwight

CHD

Analysis

BobbyInvestment Opinion: Should I buy PG Today?

We rate PG as a Hold. The stock offers defensive qualities and a solid dividend, but its growth prospects are limited, and the valuation is not compelling. The consensus rating is 'Buy' with an average target of $160.57, implying 11.1% upside, but this is modest for the risk taken. The thesis is that PG is a quality company facing cyclical headwinds, and investors should wait for a better entry point or evidence of volume recovery.

Sign up to view all

PG 12-Month Price Forecast

PG's outlook is balanced, with the potential for modest upside if volume recovers, but downside risks from cost pressures and valuation. The stock is likely to trade in a range, with the base case being a slow grind higher. I would upgrade to bullish if volume growth turns positive and margins stabilize, and downgrade to bearish if the company cuts guidance or the dividend.

Historical Price
Current Price $144.68
Average Target $152.50
High Target $186.00
Low Target $130.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $160.57 and implied upside of +11.0% versus the current price.

Average Target

$160.57

0 analysts

Implied Upside

+11.0%

vs. current price

Analyst Count

covering this stock

Price Range

$143 - $186

Analyst target range

The target price range spans from a low of $143.00 to a high of $186.00, with the average at $160.57. The high target of $186.00 implies a potential upside of 28.7% from the current price, suggesting that some analysts see significant room for recovery, possibly driven by a rebound in volume growth or successful cost mitigation. The low target of $143.00 is slightly below the current price, indicating that some analysts see limited downside but also limited upside, possibly pricing in persistent volume declines or margin pressure. The spread between the low and high targets is $43.00, which is about 29.7% of the average target, indicating a moderate level of uncertainty. Recent institutional ratings show no major upgrades or downgrades, with firms like B of A Securities reiterating Buy and Wells Fargo maintaining Overweight, suggesting a stable but cautious optimism.

Drowning in data?

Find the real signal!

Bulls vs Bears: PG Investment Factors

PG presents a mixed picture: its defensive qualities, strong margins, and reliable dividend are offset by sluggish volume growth, cost pressures, and a rich valuation. The bull case rests on the potential for volume recovery and cost mitigation, while the bear case highlights the risk of continued underperformance and valuation de-rating. Currently, the bearish evidence is slightly stronger given the lack of volume growth and the stock's significant underperformance versus the market. The key tension is whether PG can reignite organic volume growth; if it does, the stock could re-rate higher, but if not, the premium valuation may compress further.

Bullish

  • Strong Q3 Revenue Acceleration: Q3 FY2026 revenue grew 7.38% YoY to $21.235B, a significant acceleration from the 2.1% growth in Q2 and 2.99% in Q1, indicating improving demand trends and successful pricing actions.
  • Robust Profitability Metrics: PG maintains a gross margin of 50.2% and an operating margin of 22.7%, reflecting strong brand pricing power and operational efficiency, which supports continued earnings generation.
  • Attractive Dividend Yield: With a dividend yield of 2.88% and a payout ratio of 63.8%, PG offers a reliable income stream, backed by 68 consecutive years of dividend increases, appealing to income-focused investors.
  • Low Beta Defensive Characteristics: PG's beta of 0.377 indicates low volatility relative to the market, making it a defensive anchor in portfolios during economic uncertainty, as evidenced by its relative strength during market downturns.

Bearish

  • Persistent Volume Declines: Despite revenue growth, organic volume has been declining, as highlighted by the Motley Fool article noting that the stock isn't a buy until volume growth returns, suggesting that recent growth is price-driven and unsustainable.
  • Cost Headwinds Pressuring Margins: Fiscal 2027 guidance fell short due to $1.36B in cost headwinds, which could compress margins and limit earnings growth, as input costs for commodities and logistics remain elevated.
  • Underperformance Relative to Market: PG's stock declined 5.98% over the past year while the S&P 500 gained 20.37%, and its relative strength over 1 year is -26.35%, indicating significant underperformance and potential investor frustration.
  • High Valuation with Low Growth: The trailing PE of 21.72x and forward PE of 19.53x are elevated for a company with expected EPS growth of only ~1.2%, resulting in a PEG ratio of 18.11x, suggesting the stock is overvalued relative to its growth prospects.

PG Technical Analysis

PG's price trend over the past year has been predominantly downward, with the stock declining 5.98% over the past 12 months, a stark contrast to the S&P 500's gain of 20.37% during the same period. Currently trading at $144.55, the stock sits at approximately 62% of its 52-week range (between $137.62 low and $167.25 high), indicating it is closer to the lower end of its yearly band. This positioning suggests a defensive posture, with the stock having lost momentum after peaking in early 2026, and it may be viewed as either a value opportunity or a falling knife depending on one's outlook on consumer staples.

Beta

0.38

0.38x market volatility

Max Drawdown

-16.1%

Largest decline past year

52-Week Range

$138-$167

Price range past year

Annual Return

-8.9%

Cumulative gain past year

PeriodPG ReturnS&P 500
1m-3.0%+2.5%
3m+0.2%+2.7%
6m-10.0%+11.1%
1y-8.9%+20.5%
ytd+2.0%+12.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

PG Fundamental Analysis

PG's revenue trajectory shows moderate growth, with the most recent quarter (Q3 FY2026, ended March 31, 2026) reporting revenue of $21.235 billion, a 7.38% year-over-year increase. This growth is a rebound from the prior year's Q3 revenue of $19.776 billion, and it represents an acceleration from the 2.1% growth seen in Q2 FY2026 (revenue of $22.208 billion vs. $21.882 billion in Q2 FY2025). However, the multi-quarter trend is mixed: Q1 FY2026 revenue grew 2.99% year-over-year, while Q4 FY2025 saw a 1.74% increase, indicating that the latest quarter's growth is a positive outlier. Segment-wise, Fabric Care and Home Care remains the largest segment at $7.403 billion, followed by Baby, Feminine and Family Care at $5.058 billion, with Beauty at $3.866 billion, Health Care at $3.073 billion, and Grooming at $1.608 billion, though segment growth rates are not provided.

Quarterly Revenue

$21.2B

2026-03

Revenue YoY Growth

+7.4%

YoY Comparison

Gross Margin

49.5%

Latest Quarter

Free Cash Flow

$15.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Baby, Feminine and Family Care Segment Member
Beauty Segment
Fabric Care And Home Care Segment Member
Grooming Segment Member
Health Care Segment Member

Open an Account, get $2 TSLA now!

Valuation Analysis: Is PG Overvalued?

Given PG's positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE stands at 21.72x, while the forward PE is 19.53x, implying that the market expects earnings growth of approximately 11% over the next year, as the forward PE is lower. This gap suggests a modest growth expectation, which is consistent with PG's mature industry status. The PEG ratio of 18.11x, however, indicates that the stock is expensive relative to its expected earnings growth rate, which is only about 1.2% based on the implied growth from the PE differential, making the PEG ratio misleadingly high due to low growth expectations.

PE

21.7x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 19x~31x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

17.9x

Enterprise Value Multiple

Investment Risk Disclosure

Financial risks include PG's high payout ratio of 63.8%, which limits financial flexibility and could be at risk if earnings decline. The company's debt-to-equity ratio of 0.645 is manageable, but rising interest expenses (Q3 interest expense of $223M) could pressure net income if rates remain high. Additionally, the current ratio of 0.677 indicates potential liquidity concerns, though this is typical for consumer staples with strong cash flows. The $1.36B cost headwind in fiscal 2027 could compress margins, and if volume growth remains elusive, earnings could stagnate, making the high PE multiple unsustainable.

FAQ

The key risks of holding PG include: 1) Volume declines: Organic volume has been negative, and if this persists, revenue growth will stagnate. 2) Cost inflation: The $1.36B cost headwind in fiscal 2027 could compress margins and hurt earnings. 3) Valuation risk: The stock trades at a premium PE, and any disappointment could lead to multiple compression. 4) Competitive pressure: Private labels and smaller brands could erode market share, especially if PG raises prices. 5) Macro risks: A recession could lead to consumer downtrading, and rising interest rates could make the dividend yield less attractive. The most severe risk is a combination of volume declines and cost pressures, which could lead to earnings misses and a de-rating of the stock.

The 12-month forecast for PG is for modest upside, with a base case target of $145-$160, representing a 0-11% return. The bull case, with a 25% probability, targets $160-$186, driven by volume recovery and cost mitigation. The bear case, also with a 25% probability, targets $130-$143, if volume declines and costs escalate. The most likely scenario is the base case, where PG continues to grow revenue through pricing but volumes remain flat, and the stock trades in line with its historical valuation. The average analyst target of $160.57 suggests a consensus view of moderate upside. Investors should monitor volume trends and cost guidance for signs of which scenario will play out.

PG is currently fairly valued to slightly overvalued based on its growth prospects. The trailing PE of 21.72x is above the historical average for consumer staples, and the PEG ratio of 18.11x indicates that the stock is expensive relative to its expected earnings growth of only ~1.2%. The forward PE of 19.53x suggests the market expects some acceleration, but this may be optimistic given the cost headwinds. Compared to peers, PG trades at a premium, reflecting its brand strength and defensive nature. The valuation implies that investors are paying up for safety and dividend reliability, which may be justified in uncertain times, but it leaves little margin of safety. A fair value estimate based on a 20x forward PE would be around $135, suggesting the stock is slightly overvalued at $144.55.

PG is a good stock to buy for investors seeking a reliable dividend and defensive characteristics, but it is not a compelling buy at current levels. The stock offers a 2.88% dividend yield and a low beta of 0.377, making it a stable income play. However, with a trailing PE of 21.72x and limited growth prospects, the upside is modest. The average analyst target of $160.57 implies an 11.1% upside, but the stock has underperformed the market significantly over the past year. A better entry point would be near the 52-week low of $137.62 or below, where the risk/reward improves. For long-term investors, PG can be a core holding, but for those seeking growth, there are better opportunities.

PG is best suited for long-term investment, given its defensive nature, low beta (0.377), and reliable dividend. The stock is not ideal for short-term trading due to its low volatility and lack of momentum. Over the long term, PG has historically provided steady returns through dividends and modest capital appreciation, making it a core holding for income-focused investors. The company's strong brand portfolio and global scale provide a durable competitive advantage. However, investors should be prepared for periods of underperformance, as seen in the past year. A minimum holding period of 5 years is recommended to ride out cyclical downturns and benefit from dividend compounding. For short-term traders, there are more volatile opportunities in the market.